Variant report
Variant | esv2761229 |
---|---|
Chromosome Location | chr8:3824446-3824874 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:3823058..3824890-chr8:3826094..3828395,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2740822 | chr8:3824446-3824447 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs79287279 | chr8:3824455-3824456 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs574288698 | chr8:3824497-3824498 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs541708827 | chr8:3824507-3824508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530179361 | chr8:3824510-3824511 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs2407194 | chr8:3824516-3824517 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs545911054 | chr8:3824518-3824519 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533136967 | chr8:3824519-3824520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs138269284 | chr8:3824524-3824525 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2627473 | chr8:3824530-3824531 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs185824471 | chr8:3824531-3824532 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs56322849 | chr8:3824533-3824534 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561496440 | chr8:3824542-3824543 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs529062915 | chr8:3824565-3824566 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547228999 | chr8:3824578-3824579 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs565832717 | chr8:3824585-3824586 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs79739079 | chr8:3824591-3824592 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs529575421 | chr8:3824597-3824598 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs549279494 | chr8:3824598-3824599 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs142862395 | chr8:3824603-3824604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs569079786 | chr8:3824615-3824616 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs537095958 | chr8:3824634-3824635 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373648456 | chr8:3824645-3824646 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs76563571 | chr8:3824652-3824653 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs573824614 | chr8:3824660-3824661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs150651508 | chr8:3824662-3824663 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs188197615 | chr8:3824668-3824669 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2627472 | chr8:3824671-3824672 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs545697868 | chr8:3824700-3824701 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs138577177 | chr8:3824703-3824704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs564481897 | chr8:3824731-3824732 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2627471 | chr8:3824735-3824736 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs539059654 | chr8:3824738-3824739 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs149306772 | chr8:3824745-3824746 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561037903 | chr8:3824750-3824751 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528608706 | chr8:3824760-3824761 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs6980578 | chr8:3824762-3824763 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs76509745 | chr8:3824769-3824770 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181065178 | chr8:3824771-3824772 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs2627470 | chr8:3824773-3824774 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs569509661 | chr8:3824783-3824784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs375348666 | chr8:3824794-3824795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs386721166 | chr8:3824796-3824797 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs74895686 | chr8:3824797-3824798 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs549048235 | chr8:3824806-3824807 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567349182 | chr8:3824807-3824808 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs534746400 | chr8:3824816-3824817 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs2554503 | chr8:3824825-3824826 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs578139317 | chr8:3824843-3824844 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538914285 | chr8:3824845-3824846 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:3822800-3830000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
2 | chr8:3823000-3824800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr8:3824000-3824600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr8:3824000-3825200 | Enhancers | Fetal Brain Male | brain |
5 | chr8:3824400-3825000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
6 | chr8:3824600-3825200 | Enhancers | HepG2 | liver |
7 | chr8:3824600-3829400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr8:3824800-3825200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |